With the shelf now effective, watch for prospectus supplements indicating an actual takedown. The company's cash needs and going-concern status make a near-term offering likely. Any announcement of a specific offering would be a material negative catalyst for the stock.
Price Chart
Executive Summary
Niki BioSolutions' $75M universal shelf registration (File No. 333-298608) became effective on October 9, 2026, following three pre-effective amendments. The company can now sell common stock, preferred stock, warrants, subscription rights, debt securities, or units in one or more offerings at its discretion. This creates a persistent dilution overhang, particularly concerning given the company's net loss widening to $1.33M in H1 2026 and a going-concern opinion from its auditor.
Key Facts
- Shelf registration effective October 9, 2026 for up to $75,000,000 in securities
- Securities include common stock, preferred stock, warrants, subscription rights, debt securities, and units
- Non-affiliate market value was $5,008,895 as of September 30, 2026, limiting primary offering size under General Instruction I.B.6
- Prior S-3/A filings noted a going-concern opinion and widening net loss ($1.33M H1 2026 vs $0.44M H1 2025)
Financial Impact
Up to $75M in potential dilution, representing ~15x the non-affiliate market value of $5M
Risk Factors
- Immediate dilution if company conducts an offering
- Stock price pressure from overhang even without an actual offering
- Limited non-affiliate market value may force a dilutive structure (e.g., registered direct or at-the-market offering)
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003200 |
| Document: 9999999995-26-003200-index.html | 9999999995-26-003200 |
| Document: 9999999995-26-003200.txt | 9999999995-26-003200 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | EFFECT | $2.63 $2.03 | ▲ +22.67% | ▲ +21.52% | $1.90 (+27.62%) |
Oct 2, 2026 23d ago | S-3/A | $4.73 $3.02 | ▲ +36.13% | ▲ +36.55% | $1.90 (+59.82%) |
Sep 25, 2026 4w ago | Press Release | $4.76 $4.60 | ▼ −3.36% | ▼ −3.14% | $1.90 (−60.08%) |
Sep 18, 2026 5w ago | S-3/A | $4.97 $4.70 | ▲ +5.43% | ▲ +4.41% | $1.90 (+61.77%) |
Aug 27, 2026 8w ago | S-3 | $6.90 $6.20 | ▲ +10.14% | ▲ +10.25% | $1.90 (+72.46%) |
Aug 7, 2026 11w ago | 8-K | $8.62 $8.26 | ▼ −4.18% | ▼ −4.13% | $1.90 (−77.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers